Literature DB >> 28687562

Efficacy and safety of the subcutaneous implantable cardioverter defibrillator: a systematic review.

Colin Dominic Chue1, Chun Shing Kwok1,2, Chun Wai Wong2, Ashish Patwala1, Diane Barker1, Amir Zaidi3, Mamas A Mamas1,2, Colin Cunnington3, Fozia Z Ahmed3.   

Abstract

BACKGROUND: Subcutaneous implantable cardioverter defibrillators (S-ICDs) are considered an alternative to conventional transvenous ICDs (TV-ICDs) in patients not requiring pacing.
METHODS: We searched MEDLINE and EMBASE for studies evaluating efficacy and safety outcomes in S-ICD patients. Outcomes were pooled across studies.
RESULTS: Sixteen studies were included with 5380 participants (mean age range 33-56 years). Short-term follow-up data were available for 1670 subjects. The most common complication was pocket infection, affecting 2.7%. Other complications included delayed wound healing (0.6%) and wound discomfort (0.8%). 3.8% of S-ICDs were explanted, most commonly for pocket infection. Mortality rates in hospital (0.4%) and during follow-up (3.4% from 12 studies reporting) were low. Incidence of ventricular arrhythmia varied from 0% to 12%. Overall shock efficacy exceeded 96%. Inappropriate shocks affected 4.3% and was most commonly caused by T-wave oversensing.
CONCLUSIONS: Although long-term randomised data are lacking, observational data suggest similar shock efficacy and short-term complication rates between the S-ICD and TV-ICD. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  implanted cardiac defibrillators; systematic review; ventricular fibrillation; ventricular tachycardia

Mesh:

Year:  2017        PMID: 28687562     DOI: 10.1136/heartjnl-2016-310852

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  5 in total

1.  The utility of routine clinical 12-lead ECG in assessing eligibility for subcutaneous implantable cardioverter defibrillator.

Authors:  Jason A Thomas; Erick Andres Perez-Alday; Christopher Hamilton; Muammar M Kabir; Eugene A Park; Larisa G Tereshchenko
Journal:  Comput Biol Med       Date:  2018-05-08       Impact factor: 4.589

2.  Initial experience with the subcutaneous implantable cardioverter-defibrillator with the real costs of hospitalization analysis in a single Polish center.

Authors:  Marcin Grabowski; Monika Gawałko; Marcin Michalak; Andrzej Cacko; Michał Kowara; Agnieszka Kołodzińska; Łukasz Januszkiewicz; Paweł Balsam; Laura Vitali Serdoz; Joachim Winter; Grzegorz Opolski
Journal:  Cardiol J       Date:  2018-04-03       Impact factor: 2.737

3.  Efficacy, safety, and in-hospital outcomes of subcutaneous versus transvenous implantable defibrillator therapy: A meta-analysis and systematic review.

Authors:  Chao-Feng Chen; Chao-Lun Jin; Mei-Jun Liu; Yi-Zhou Xu
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

4.  Induced atrial fibrillation during defibrillation test on implantation of subcutaneous implantable cardioverter defibrillator.

Authors:  Ki-Hun Kim; Sang-Hoon Seol; Jino Park; Yeo-Jeong Song; Seunghwan Kim; Dong-Kie Kim
Journal:  J Geriatr Cardiol       Date:  2020-08       Impact factor: 3.327

5.  The first use of a rotating mechanical dilator sheath for S-ICD coil extraction.

Authors:  Kavisha Patel; Nicola Tarantino; Jeremy Miles; Xiao-Dong Zhang; Jay Gross
Journal:  HeartRhythm Case Rep       Date:  2019-08-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.